Literature DB >> 24509327

Clotting factor level is not a good predictor of bleeding in carriers of haemophilia A and B.

Anna Olsson1, Margareta Hellgren, Erik Berntorp, Rolf Ljung, Fariba Baghaei.   

Abstract

Carriers of haemophilia are known to have a wide range of clotting factor levels and bleeding symptoms. This study aimed at investigating whether carriers of severe and moderate haemophilia had an increased bleeding tendency, compared with a control group, using a condensed version of a bleeding assessment tool developed by the Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD study group (MCMDM-1VWD). One hundred and twenty-six genetically verified carriers of severe and moderate haemophilia and 90 controls were interviewed regarding bleeding symptoms. A bleeding score of at least 4 was considered positive, indicating a significant bleeding tendency. Clotting factor levels were tested in the carriers.Nineteen of the women were carriers of haemophilia B, with a mean factor (F)IX:C level of 0.54 (± 0.27) kIU/l, and 107 were carriers of haemophilia A, with a mean FVIII:C level of 0.74 (± 0.32) kIU/l. The median bleeding score was 2 (-3-12) among carriers and -1 (-3-8) among controls (P < 0.001). The bleeding score was weakly correlated to clotting factor levels in carriers of haemophilia A (rs = -0.36, P < 0.001). We conclude that the bleeding tendency in our cohort of carriers differed significantly from that in the controls and that clotting factor levels might not be sufficient to predict the bleeding tendency.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24509327     DOI: 10.1097/MBC.0000000000000083

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  12 in total

1.  Mathematical model of thrombin generation and bleeding phenotype in Amish carriers of Factor IX:C deficiency vs. controls.

Authors:  S Gupta; M C Bravo; M Heiman; C Nakar; K Brummel-Ziedins; C H Miller; A Shapiro
Journal:  Thromb Res       Date:  2019-08-08       Impact factor: 3.944

Review 2.  Diagnosis and care of patients with mild haemophilia: practical recommendations for clinical management.

Authors:  Gary Benson; Günter Auerswald; Gerry Dolan; Anne Duffy; Cedric Hermans; Rolf Ljung; Massimo Morfini; Silva Zupančić Šalek
Journal:  Blood Transfus       Date:  2017-11-14       Impact factor: 3.443

3.  A decreased and less sustained desmopressin response in hemophilia A carriers contributes to bleeding.

Authors:  Victoria Candy; Hilary Whitworth; Julie Grabell; Lisa Thibeault; Lori Harpell; Mackenzie Bowman; David Good; Wilma M Hopman; Robert F Sidonio; Paula D James
Journal:  Blood Adv       Date:  2018-10-23

4.  Women and girls with haemophilia receiving care at specialized haemophilia treatment centres in the United States.

Authors:  Connie H Miller; J Michael Soucie; Vanessa R Byams; Amanda B Payne; Robert F Sidonio; Tyler W Buckner; Christopher J Bean
Journal:  Haemophilia       Date:  2021-09-04       Impact factor: 4.263

5.  A cross-sectional study of bleeding phenotype in haemophilia A carriers.

Authors:  Allison Paroskie; Dave Gailani; Michael R DeBaun; Robert F Sidonio
Journal:  Br J Haematol       Date:  2015-04-01       Impact factor: 6.998

6.  Women and girls with haemophilia and bleeding tendencies: Outcomes related to menstruation, pregnancy, surgery and other bleeding episodes from a retrospective chart review.

Authors:  Ateefa Chaudhury; Robert Sidonio; Nisha Jain; Elisa Tsao; Justyna Tymoszczuk; Mariana Oviedo Ovando; Roshni Kulkarni
Journal:  Haemophilia       Date:  2020-12-24       Impact factor: 4.287

Review 7.  Genetic causes of haemophilia in women and girls.

Authors:  Connie H Miller; Christopher J Bean
Journal:  Haemophilia       Date:  2020-12-13       Impact factor: 4.263

Review 8.  Prevalence of symptoms in hemophilia carriers in comparison with the general population: a systematic review.

Authors:  André Bubna Hirayama; Alline Karolyne Cândida da Silva; Jordanna Sousa Rocha; Maria do Rosário Ferraz Roberti
Journal:  Hematol Transfus Cell Ther       Date:  2019-06-17

9.  X Chromosome inactivation: a modifier of factor VIII and IX plasma levels and bleeding phenotype in Haemophilia carriers.

Authors:  Isabella Garagiola; Mimosa Mortarino; Simona Maria Siboni; Marco Boscarino; Maria Elisa Mancuso; Marina Biganzoli; Elena Santagostino; Flora Peyvandi
Journal:  Eur J Hum Genet       Date:  2020-10-20       Impact factor: 4.246

10.  A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH.

Authors:  Karin P M van Galen; Roseline d'Oiron; Paula James; Rezan Abdul-Kadir; Peter A Kouides; Roshni Kulkarni; Johnny N Mahlangu; Maha Othman; Flora Peyvandi; Dawn Rotellini; Rochelle Winikoff; Robert F Sidonio
Journal:  J Thromb Haemost       Date:  2021-08       Impact factor: 16.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.